UPDATE: Auxilium Posts Upbeat Q3 Profit
Auxilium Pharmaceuticals (NASDAQ: AUXL) reported an upbeat third-quarter profit and narrowed its revenue outlook for the full year.
Auxilium now projects full-year revenue of $370 million to $401 million, versus its prior forecast of $363 million to $405 million.
Auxilium posted a quarterly net loss of $28.9 million, or $0.59 per share, versus a year-ago loss of $10.5 million, or $0.21 per share. Excluding items, it earned $0.17 per share.
Its net revenue rose 52% to $108.1 million. However, analysts were expecting a profit of $0.15 per share on revenue of $103.7 million.
Auxilium shares gained 5.55% to $18.25 in pre-market trading.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.